Company ME Therapeutics Holdings Inc. Deutsche Boerse AG
Equities
Q9T
CA5527671054
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 EUR | 0.00% |
|
-7.87% | +251.88% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Salim Dhanji
CEO | Chief Executive Officer | 44 | 23-03-08 |
Quinn Martin
DFI | Director of Finance/CFO | 42 | 23-03-08 |
Jamil Kassam
SEC | Corporate Secretary | 44 | 23-03-08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Karim Nanji
BRD | Director/Board Member | 57 | 23-06-06 |
Salim Dhanji
CEO | Chief Executive Officer | 44 | 23-03-08 |
Kenneth Harder
BRD | Director/Board Member | 57 | 23-03-08 |
John Priatel
BRD | Director/Board Member | 58 | 23-03-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,189,494 | 12,670,509 ( 50.30 %) | 0 | 50.30 % |
Company contact information
![address ME Therapeutics Holdings Inc.(Q9T)](https://cdn.zonebourse.com/static/address/162926788.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+37.55% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |
- Stock Market
- Equities
- METX Stock
- Q9T Stock
- Company ME Therapeutics Holdings Inc.